Mimi Kim

14.3k citations

196 papers · 8.3k · 2 hit papers · h-index 50

Impact in

Rheumatology top 0.1%
- Systemic Lupus Erythematosus Research
Nephrology top 1%
- Renal Diseases and Glomerulopathies

Papers in

Rheumatology 39
- Systemic Lupus Erythematosus Research 37
Oncology 19
- Cancer Risks and Factors 9

Co-authors: Jill P. Buyon (30 shared papers)Michelle Petri (11 shared papers)Joan T. Merrill (14 shared papers)Deborah Friedman (11 shared papers)Thomas E. Rohan (27 shared papers)Peter Izmirly (15 shared papers)Geoffrey C. Kabat (22 shared papers)Carolina Llanos (5 shared papers)
Journals: Cancer Causes & Control (8 papers)Statistics in Medicine (7 papers)Lupus Science & Medicine (5 papers)Annals of the Rheumatic Diseases (5 papers)Pediatric Blood & Cancer (4 papers)
Partner nations: United States France Canada

In The Last Decade

Mimi Kim

189 papers receiving 7.9k citations

Mimi Kim's Hit Papers

align trajectories log scale

Predictors of Pregnancy Outcomes in Patients With Lupus 2015 · 379 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Annals of Internal Medicine
2005 New England Journal of Medicine

Peers

Countries citing papers authored by Mimi Kim

Since Specialization

Citations

This map shows the geographic impact of Mimi Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mimi Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mimi Kim more than expected).

Fields of papers citing papers by Mimi Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mimi Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mimi Kim. The network helps show where Mimi Kim may publish in the future.

Co-authors

The 25 scholars most cited alongside Mimi Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mimi Kim Line = papers co-authored together Mimi Kim links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 196 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis New England Journal of Medicine ·Ellen M. Ginzler, Mary Anne Dooley, Cynthia Aranow, Mimi Kim, Jill P. Buyon, Joan T. Merrill, Michelle Petri, Gary S. Gilkeson, Daniel J. Wallace, Michael H. Weisman, Gerald B. Appel Hit paper breakdown →	2005	838
2	Predictors of Pregnancy Outcomes in Patients With Lupus Annals of Internal Medicine ·Jill P. Buyon, Mimi Kim, Marta Guerra, Carl A. Laskin, Michelle Petri, Michael D. Lockshin, Lisa R. Sammaritano, D. Ware Branch, T. Flint Porter, Allen D. Sawitzke, Joan T. Merrill, Mary D. Stephenson, Elisabeth Cohn, Lamya Garabet, Jane E. Salmon Hit paper breakdown →	2015	379
3	Maternal Use of Hydroxychloroquine Is Associated With a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody–Associated Cardiac Manifestations of Neonatal Lupus Circulation ·Peter Izmirly, N. Costedoat‐Chalumeau, Cecilia Pisoni, Munther A. Khamashta, Mimi Kim, Amit Saxena, Deborah Friedman, Carolina Llanos, Jean‐Charles Piette, Jill P. Buyon	2012	295
4	Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies Arthritis & Rheumatism ·Michael D. Lockshin, Mimi Kim, Carl A. Laskin, Marta Guerra, D. Ware Branch, Joan T. Merrill, Michelle Petri, T. Flint Porter, Lisa R. Sammaritano, Mary D. Stephenson, Jill P. Buyon, Jane E. Salmon	2012	282
5	Motor stereotypies in children with autism and other developmental disorders Developmental Medicine & Child Neurology ·Sylvie Goldman, Cuiling Wang, Miran Salgado, Paul Greene, Mimi Kim, Isabelle Rapin	2008	228
6	Classification and definition of major flares in SLE clinical trials Lupus ·Michelle Petri, Jill P. Buyon, Mimi Kim	1999	224
7	Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block Circulation ·Deborah Friedman, Mimi Kim, Joshua A. Copel, Claudine Davis, Colin K. L. Phoon, Julie S. Glickstein, Jill P. Buyon	2008	211
8	Maternal and Fetal Factors Associated With Mortality and Morbidity in a Multi–Racial/Ethnic Registry of Anti-SSA/Ro–Associated Cardiac Neonatal Lupus Circulation ·Peter Izmirly, Amit Saxena, Mimi Kim, Dan Wang, Sara Sahl, Carolina Llanos, Deborah Friedman, Jill P. Buyon	2011	193
9	Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility Cancer Cell ·Guohze Yang, Stefan Scherer, Scarlet S. Shell, Kan Yang, Mimi Kim, Martin Lipkin, Raju Kucherlapati, Richard D. Kolodner, Winfried Edelmann	2004	135
10	Robust detection of traumatic axonal injury in individual mild traumatic brain injury patients: Intersubject variation, change over time and bidirectional changes in anisotropy Brain Imaging and Behavior ·Michael L. Lipton, Namhee Kim, Young K. Park, Miriam Hulkower, Tova Gardin, Keivan Shifteh, Mimi Kim, Molly E. Zimmerman, Richard B. Lipton, Craig A. Branch	2012	128
11	Prospective Evaluation of Fetuses With Autoimmune-Associated Congenital Heart Block Followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study The American Journal of Cardiology ·Deborah Friedman, Mimi Kim, Joshua A. Copel, Carolina Llanos, Claudine Davis, Jill P. Buyon	2009	127
12	Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study American Journal of Obstetrics and Gynecology ·Mimi Kim, Jill P. Buyon, Marta Guerra, Sarosh Rana, Dongsheng Zhang, Carl A. Laskin, Michelle Petri, Michael D. Lockshin, Lisa R. Sammaritano, D. Ware Branch, T. Flint Porter, Joan T. Merrill, Mary D. Stephenson, Qi Gao, S. Ananth Karumanchi, Jane E. Salmon	2015	126
13	The effect of moderate‐dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: Findings of a prospective, randomized, double‐blind, placebo‐controlled trial Arthritis & Rheumatism ·Chung‐E Tseng, Jill P. Buyon, Mimi Kim, H. Michael Belmont, Meggan Mackay, Betty Diamond, Galina Marder, Perry Rosenthal, Kathleen Haines, Virginia Ilie, Steven B. Abramson	2006	124
14	Incident Cardiovascular Disease Events in Metabolically Benign Obese Individuals Obesity ·Alexandra D. Ogorodnikova, Mimi Kim, Aileen P. McGinn, Paul Muntner, Unab I. Khan, Rachel P. Wildman	2011	123
15	Insulin-Like Growth Factor Axis and Risk of Type 2 Diabetes in Women Diabetes ·Swapnil Rajpathak, Meian He, Qi Sun, Robert C. Kaplan, Radhika Muzumdar, Thomas E. Rohan, Marc J. Gunter, Michaël Pollak, Mimi Kim, Jeffrey E. Pessin, Jeannette M. Beasley, Judith Wylie‐Rosett, Frank B. Hu, Howard D. Strickler	2012	123
16	Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies Annals of the Rheumatic Diseases ·Mimi Kim, Marta Guerra, Elianna Kaplowitz, Carl A. Laskin, Michelle Petri, D. Ware Branch, Michael D. Lockshin, Lisa R. Sammaritano, Joan T. Merrill, T. Flint Porter, Allen D. Sawitzke, Anne M. Lynch, Jill P. Buyon, Jane E. Salmon	2018	122
17	Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer International Journal of Cancer ·Geoffrey C. Kabat, Mimi Kim, Bette J. Caan, Rowan T. Chlebowski, Marc J. Gunter, Gloria Ho, Beatriz L. Rodríguez, James M. Shikany, Howard D. Strickler, Mara Z. Vitolins, Thomas E. Rohan	2009	122
18	Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III Gynecologic Oncology ·Mark H. Einstein, Anna S. Kadish, Robert D. Burk, Mimi Kim, Scott Wadler, Howard Streicher, Gary L. Goldberg, Carolyn D. Runowicz	2007	120
19	Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors Arthritis & Rheumatism ·Carolina Llanos, Peter Izmirly, Margaret Katholi, Robert M. Clancy, Deborah Friedman, Mimi Kim, Jill P. Buyon	2009	111
20	Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial The Lancet. Gastroenterology & hepatology ·Olga C. Aroniadis, Lawrence J. Brandt, Caterina Oneto, Paul Feuerstadt, Alex Sherman, Allan W. Wolkoff, Zain Kassam, Rotem Gura Sadovsky, Ryan J. Elliott, Shrish Budree, Mimi Kim, Marla J. Keller	2019	111

About Mimi Kim

Mimi Kim is a scholar working on Rheumatology, Oncology, Epidemiology, Statistics and Probability and Molecular Biology, having authored 196 papers that have together received 8.3k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (37 papers), Statistical Methods in Clinical Trials (13 papers), Traumatic Brain Injury Research (10 papers), Advanced Causal Inference Techniques (9 papers), Cancer Risks and Factors (9 papers), Statistical Methods and Inference (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Statistical Methods and Bayesian Inference (6 papers). The work is most often cited by research in Rheumatology (2.9k citations), Nephrology (509 citations), Immunology (1.3k citations), Obstetrics and Gynecology (332 citations) and Hepatology (256 citations). Mimi Kim has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Jill P. Buyon, Michelle Petri, Joan T. Merrill, Deborah Friedman, Thomas E. Rohan, Peter Izmirly, Geoffrey C. Kabat, Carolina Llanos, Jane E. Salmon and Marta Guerra. Their work appears in journals such as Cancer Causes & Control, Statistics in Medicine, Lupus Science & Medicine, Annals of the Rheumatic Diseases and Pediatric Blood & Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mimi Kim

Impact in

Papers in i

In The Last Decade

Mimi Kim

Mimi Kim's Hit Papers

Peers

Countries citing papers authored by Mimi Kim

Fields of papers citing papers by Mimi Kim

All Works

About Mimi Kim

Explore authors with similar magnitude of impact

Papers in